Vimarsana
Biggest News Aggregation in the World

Page 4 - Section Ref News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Section Ref. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Section Ref Today - Breaking & Trending Today

Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 | Pediatrics | JAMA - Vimarsana News

Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19 | Pediatrics | JAMA

1. NYC Health. 2020 Health alert 13: pediatric multi-system inflammatory syndrome potentially associated with COVID-19. Published May 4, 2020. Accessed December 3, 2020. https://www1.nyc.gov/assets/doh/downloads/pdf/han/alert/2020/covid-19-pediatric-multi-system-inflammatory-syndrome.pdf 2. Riphagen  S, Gomez  X, Gonzalez-Martinez  C, Wilkinson  N, Theocharis  P.  Hyperinflammatory shock in children during COVID-19 pandemic.  3. Verdoni  L, Mazza  A, Gervasoni  A,  et al.  An outbreak ...

Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children | Critical Care Medicine | JAMA - Vimarsana News

Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children | Critical Care Medicine | JAMA

1Assistance Publique–Hôpitaux de Paris, Department of General Paediatrics, Paediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, Université de Paris, Paris, France 2ACTIV, Association Clinique et Thérapeutique Infantile du Val-de-Marne, Créteil, France 3Université de Paris, INSERM UMR 1123, ECEVE, Paris, France 4Assistance Publique–Hôpitaux de Paris, Department of General Paediatrics and Paediatric Infectious Diseases, Necker-Enfants-Malades University Hospital, Université de Paris, Paris, France 5Institut Pasteur, Biodiversity and Epidemiology of ...

An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19 - Vimarsana News

An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19

Neurodevelopmental disorders (eg, cerebral palsy) A medical-related technological dependence (eg, tracheostomy, gastrostomy, or positive pressure ventilation [not related to COVID-19]) Asthma, reactive airway or other chronic respiratory disease that requires daily treatment Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease. a Patients ≥12 years old who weigh ≥40 kg with ≥1 of the criteria listed are considered at high risk for progressing to severe COVID-19 and/or hospitalization. FDA fact sheet for health care providers emergency use authorization (EUA) ...